| AE/AEs | Auger Electron/Auger Electrons |
| AI | Artificial Intelligence |
| ALP | Alkaline Phosphatase |
| BFC | Bifunctional Chelator |
| BP | Bisphosphonate |
| BPAMD | Bisphosphonate derivative/DOTA-bisphosphonate derivative |
| CE | Conversion Electron |
| CT | Computed Tomography |
| DOTA | 1,4,7,10-tetraazacyclododecane-1,4,7,10-tetraacetic acid |
| DOTAM | 1,4,7,10-tetrakis(carbamoylmethyl)-1,4,7,10-tetraazacyclododecane |
| DOTATATE DOTATOC DOTANOC | DOTA-conjugated somatostatin analogs |
| DOTAZOL | DOTA-conjugated zoledronate derivative |
| DOTMP | 1,4,7,10-tetraazacyclododecane-1,4,7,10-tetrakis(methylenephosphonic acid) |
| DMSA | Dimercaptosuccinic acid |
| DTPA | Diethylene triamine pentaacetic acid |
| DTMP | Diethylenetriamine tetramethylene phosphonic acid |
| EC | Electron Capture |
| EDTMP | Ethylenediamine tetramethylenephosphonic acid |
| EGF | Epidermal Growth Factor |
| EGFR | Epidermal Growth Factor Receptor |
| EMA | European Medicines Agency |
| FAPI | Fibroblast Activation Protein Inhibitor |
| FDA | Food and Drug Administration |
| FDG | Fluorodeoxyglucose |
| FGFs | Fibroblast Growth Factors |
| HDP/HMDP | Hydroxymethylene diphosphonate |
| HEDP | Hydroxyethylidene diphosphonate |
| HEDTA | N-hydroxyethylene diamine triacetic acid |
| HYNIC | Hydrazinonicotinamide |
| IBA | Ibandronate |
| IGFs | Insulin-like Growth Factors |
| IL-6 | Interleukin-6 |
| LET | Linear Energy Transfer |
| MABG | Meta-alpha-astatobenzylguanidine |
| MAG3 | Mercaptoacetyltriglycine |
| mCRPC | Metastatic Castration-Resistant Prostate Cancer |
| MDP | Methylene Diphosphonate |
| MIBG | Metaiodobenzylguanidine |
| MRI | Magnetic Resonance Imaging |
| NaF | Sodium Fluoride |
| NOTA | 1,4,7-triazacyclononane-1,4,7-triacetic acid |
| NSCLC | Non-Small Cell Lung Cancer |
| OPG | Osteoprotegerin |
| PARP | Poly(ADP-ribose) Polymerase |
| PARPi | PARP Inhibitor |
| PET | Positron Emission Tomography |
| PSA | Prostate-Specific Antigen |
| PSMA | Prostate-Specific Membrane Antigen |
| PTHrP | Parathyroid Hormone-related Protein |
| RANK | Receptor Activator of Nuclear Factor-κB |
| RANKL | Receptor Activator of Nuclear Factor-κB Ligand |
| SPECT | Single Photon Emission Computed Tomography |
| SREs | Skeletal-Related Events |
| SUV | Standardized Uptake Value |
| TAT | Targeted Alpha Therapy |
| TGF-β | Transforming Growth Factor-beta |
| TME | Tumor Microenvironment |
| TNF-α | Tumor Necrosis Factor-alpha |
| TRT | Targeted Radionuclide Therapy |
| TTP | Time to Progression |
| VEGF | Vascular Endothelial Growth Factor |
| VEGFR | Vascular Endothelial Growth Factor Receptor |
| WBRT | Whole-Brain Radiation Therapy |
| WHO | World Health Organization |
| ZOL | Zoledronic Acid/Zoledronate |